Unlocking acid ceramidase: a new weapon against proteasome chemoresistance in myeloma

Unlocking acid ceramidase: a new weapon against proteasome chemoresistance in myeloma

Not available.

Saved in:

Bibliographic Details
Main Author:	Jesus Delgado-Calle
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2025-01-01
Series:	Haematologica
Online Access:	https://haematologica.org/article/view/11890
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Acid ceramidase controls proteasome inhibitor resistance and is a novel therapeutic target for the treatment of relapsed / refractory multiple myeloma
by: Ryan T. Bishop, et al.
Published: (2024-12-01)

Omega-3 fatty acids: molecular weapons against chemoresistance in breast cancer
by: Vittoria Marchio, et al.
Published: (2025-01-01)

Phase I study of TQB3602, an oral proteasome inhibitor, in relapsed and refractory multiple myeloma
by: Wenjiao Tang, et al.
Published: (2024-07-01)

Proteasome inhibition enhances oncolytic reovirus therapy in multiple myeloma independently of its direct cytotoxic effects
by: Ada Alice Dona, et al.
Published: (2025-01-01)

Weapons of Moths against Bats and Their Bionic Applications
by: Jia Tianqi
Published: (2024-01-01)

Serum indicators in functional high-risk multiple myeloma patients undertaking proteasome inhibitors therapy: a retrospective study
by: Linquan Zhan, et al.
Published: (2024-12-01)

Fecal microbiota transplantation: lights and shadows of a new weapon against inflammatory bowel disease
by: Andrea Piccioni, et al.
Published: (2023-03-01)

ZHX2 mediates proteasome inhibitor resistance via regulating nuclear translocation of NF‐κB in multiple myeloma
by: Jifeng Jiang, et al.
Published: (2020-10-01)

Busulfan and cyclophosphamide for autologous stem cell transplantation in patients with multiple myeloma after proteasome inhibitor and/or immunomodulatory drug treatment
by: Min Ji Jeon, et al.
Published: (2024-11-01)

Lactoferrin: a secret weapon in the war against pathogenic bacteria
by: Lucero Ruiz-Mazón, et al.
Published: (2024-10-01)

Molecular insights unlocking therapeutic potential for multiple myeloma and bone disease management
by: Tiziana Bruno, et al.
Published: (2024-12-01)

Biosynthesis of lactacystin as a proteasome inhibitor
by: Takeshi Tsunoda, et al.
Published: (2025-01-01)

Fortilin binds CTNNA3 and protects it against phosphorylation, ubiquitination, and proteasomal degradation to guard cells against apoptosis
by: Mari Nakashima, et al.
Published: (2025-01-01)

Small Arms and Light Weapons: new round of contradictions
by: A. A. Orlov
Published: (2010-08-01)

Proteasome inhibition triggers tissue-specific immune responses against different pathogens in C. elegans.
by: Manish Grover, et al.
Published: (2024-03-01)

In Vivo Pharmacodynamic Imaging of Proteasome Inhibition
by: Erin A. Kimbrel, et al.
Published: (2009-05-01)

Ubiquitin Proteasome System in Stress and Disease
by: Dmitry Karpov, et al.
Published: (2012-01-01)

Bufalin targets the SRC-3/c-Myc pathway in chemoresistant cells to regulate metastasis induced by chemoresistance in colorectal cancer
by: Jinbao Chen, et al.
Published: (2025-02-01)

New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy
by: Claudia Fabiani, et al.
Published: (2020-01-01)

ON THE ISSUE OF DEVELOPING A NEW CONCEPT OF WEAPONS CIRCULATION IN THE RUSSIAN FEDERATION
by: P. N. Mazurenko
Published: (2007-06-01)

THE EVOLVING ROLE OF PROTEASOME INHIBITORS IN CANCER TREATMENT
by: Alpay Yeşilaltay
Published: (2024-12-01)

Modern weapons and military equipment
by: Dragan M. Vučković
Published: (2025-01-01)

RESEARCH AND INNOVATIONS FOR THE WEAPONS INDUSTRY
by: Colonel (ret.) Professor Daniel DUMITRU, Ph.D, et al.
Published: (2024-12-01)

Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
by: Wang Caixia, et al.
Published: (2025-01-01)

Activators of the 26S proteasome when protein degradation increases
by: Donghoon Lee
Published: (2025-01-01)

Molecular insights into the unique properties of the blood‐circulating proteasome
by: Yegor Leushkin, et al.
Published: (2025-01-01)

Anthricin-induced hyperactive proteasome and its molecular mechanism
by: Kotaro Sakamoto, et al.
Published: (2024-12-01)

Unlocking the role of silicon against biotic stress in plants
by: Krishan K. Verma, et al.
Published: (2024-12-01)

Were weapons of the Normans and Rus' 'alive'?
by: D.V. Puzanov
Published: (2021-12-01)

Approaches to cyber weapons classification problem
by: V. V. Kabernik
Published: (2013-04-01)

DISINFORMATION - THE SECRET WEAPON OF MODERN TERRORISM
by: Sandra Sophie-Elise OLĂNESCU
Published: (2021-05-01)

Dynamics of Short Recoil-Operated Weapon
by: Martin MACKO, et al.
Published: (2021-09-01)

Weapon Barrel and Its Additional Accessories
by: Peter LISÝ, et al.
Published: (2014-03-01)

Japan and the Treaty on the Prohibition of Nuclear Weapons
by: K. G. Muratshina
Published: (2020-06-01)

SPL-108 mitigates metastasis and chemoresistance in tubo-ovarian carcinoma
by: Olivia D. Lara, et al.
Published: (2025-01-01)

Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors
by: Mary P. Udumula, et al.
Published: (2024-11-01)

Volatolomics for Anticipated Diagnosis of Cancers with Chemoresistive Vapour Sensors: A Review
by: Abhishek Sachan, et al.
Published: (2025-01-01)

Involvement of the ubiquitin-proteasome system in the regulation of the tumor microenvironment and progression
by: Yulan Huang, et al.
Published: (2025-03-01)

Suppression of the Oncogenic Transcription Factor FOXM1 by Proteasome Inhibitors
by: Andrei L. Gartel
Published: (2014-01-01)

Proteasome inhibitors related thrombotic microangiopathy: a systematic and comprehensive review
by: Can Chen, et al.
Published: (2024-11-01)